benzothiazole has been researched along with Angiogenesis, Pathologic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akunuri, R; Bhargava, SK; Jadala, C; Kamal, A; Reddy, MS; Reddy, TS; Reddy, VG; Srihari, P; Sultana, F; Wlodkowic, D | 1 |
| Azab, HA; el-Azab, MF; el-Falouji, AI; Hussein, BH | 1 |
2 other study(ies) available for benzothiazole and Angiogenesis, Pathologic
| Article | Year |
|---|---|
Pyrazolo-benzothiazole hybrids: Synthesis, anticancer properties and evaluation of antiangiogenic activity using in vitro VEGFR-2 kinase and in vivo transgenic zebrafish model.
Topics: Angiogenesis Inhibitors; Animals; Antineoplastic Agents; Apoptosis; Benzothiazoles; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Disease Models, Animal; DNA Damage; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; HEK293 Cells; Humans; Membrane Potential, Mitochondrial; Molecular Structure; Neovascularization, Pathologic; Pyrazoles; Structure-Activity Relationship; Vascular Endothelial Growth Factor Receptor-2; Wound Healing; Zebrafish | 2019 |
A novel anti-tumor agent, Ln(III) 2-thioacetate benzothiazole induces anti-angiogenic effect and cell death in cancer cell lines.
Topics: Angiogenesis Inhibitors; Animals; Anti-Bacterial Agents; Antineoplastic Agents; Benzothiazoles; Carcinoma, Ehrlich Tumor; Cell Death; Cell Line, Tumor; DNA; DNA Fragmentation; Escherichia coli; Europium; Female; Humans; Mice; Neovascularization, Pathologic; Organometallic Compounds; Salmonella; Terbium; Tumor Burden | 2012 |